Irbotan 150 Tablet

Introduction

Irbotan is a prescription medication that contains the active ingredient Irbesartan. It is available under the brand name Irbotan. Irbesartan belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). It is primarily used to treat high blood pressure (hypertension) and kidney problems caused by diabetes.

Uses

Irbotan is prescribed to help manage high blood pressure. It is also used to protect the kidneys in people with type 2 diabetes who have high blood pressure.

Dosage and Administration

The dosage of Irbotan may vary depending on the individual’s condition and response to treatment. It is typically taken once daily, with or without food. Your healthcare provider will determine the appropriate dose for you. Follow the instructions provided by your healthcare professional and not exceed the prescribed dosage.

Mechanism of Action

Irbotan works by blocking the action of a hormone called angiotensin II. Angiotensin II is responsible for narrowing the blood vessels, which can lead to increased blood pressure. By blocking the effects of angiotensin II, Irbesartan helps to relax and widen the blood vessels, allowing blood to flow more easily. This helps to lower blood pressure and improve blood flow to the kidneys.

Side Effects

Common side effects may include dizziness, headache, tiredness, and upset stomach. These side effects are usually mild and go away on their own. However, if you experience any serious side effects such as swelling of the face, lips, or throat, difficulty breathing, or signs of an allergic reaction, seek immediate medical attention.

Drug Interactions

inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements. Some medications may interact with Irbotan, potentially affecting its effectiveness or increasing the risk of side effects. Common drug interactions include nonsteroidal anti-inflammatory drugs (NSAIDs), potassium-sparing diuretics, and certain other blood pressure medications. Always consult with your healthcare provider before starting or stopping any medications while taking Irbotan.

Precautions

Before taking Irbotan, inform your healthcare provider if you have any allergies, medical conditions, or if you are pregnant or breastfeeding. This medication should not be used during pregnancy as it may harm the developing baby. It is also not recommended for use in children. Additionally, Irbotan may interact with certain substances such as alcohol or potassium supplements. Your healthcare provider will assess the risks and benefits of this medication based on your individual circumstances.

Storage

Irbotan should be stored at room temperature, away from excessive heat and moisture. Keep it out of reach of children and pets. Do not use the medication if it is past its expiration date.

Patient Tips

• Take Irbotan as prescribed by your healthcare provider.
• Follow a healthy lifestyle, including a balanced diet and regular exercise, to help manage your blood pressure.
• Avoid excessive alcohol consumption, as it may increase the risk of side effects.
• If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule.
• Contact your healthcare provider if you have any questions or concerns about your medication or experience any unusual symptoms. They are the best resource for personalized advice and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Irbesartan: medicine to treat high blood pressure (NHS UK) [Accessed 1 Jun. 2024] (online) Available at:
• Aprovel 150mg film-coated tablets (Health Professionals SmPC) Available at:
• Irbesartan (Drugs.com) [Accessed 22 Jun. 2024] (online) Available at:
• irbesartan (avapro) (RX) [Accessed 8 Jun. 2024] (online) Available at:
• Irbesartan (MedlinePlus) [Accessed 11 Jun. 2024] (online) Available at:
• Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. [Accessed 4 Jun. 2024] Available at: